MARKET

DGX

DGX

Quest Diagnostics Inc
NYSE
124.56
+2.53
+2.07%
Opening 10:43 10/03 EDT
OPEN
123.38
PREV CLOSE
122.03
HIGH
125.24
LOW
123.11
VOLUME
139.41K
TURNOVER
8.61M
52 WEEK HIGH
174.16
52 WEEK LOW
120.40
MARKET CAP
14.52B
P/E (TTM)
10.36
1D
5D
1M
3M
1Y
5Y
Eli Lilly, EQT, Cash Cows ETF, Northrop Grumman And This Diagnostics Company Feature On CNBC's Final Trade
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Pacer US Cash Cows 100 ETF (BATS: COWZ) is “a factor-b
Benzinga · 2h ago
What Fast Food And Entertainment Giants Did Traders Pick For CNBC's Fast Money Call Of The Day
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined using Benzinga Pro’s News Tool, which can be accessed on any workstation.
Benzinga · 2d ago
CNBC Halftime Report Final Trades: EQT Corp., Eli Lilly, Quest Diagnostics & Northrop Grumman
- CNBC
Benzinga · 2d ago
Should You Buy Quest Diagnostics Incorporated (NYSE:DGX) For Its Upcoming Dividend?
Readers hoping to buy Quest Diagnostics Incorporated ( NYSE:DGX ) for its dividend will need to make their move...
Simply Wall St. · 5d ago
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Benzinga · 5d ago
FDA updates COVID-19 test policy to cut emergency use requests
Revising its COVID-19 test policy, the U.S. Food and Drug Administration (FDA) said Tuesday that the agency would review only a small number of new emergency use authorization (EUA) requests for diagnostic tests.Instead, the FDA urges deve...
Seekingalpha · 5d ago
Quest Diagnostics to Release Third Quarter 2022 Financial Results on October 20, 2022
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2022 financial results on Thursday, October 20, 2022, before the market opens. It will hold its quarter...
PR Newswire · 6d ago
Quest Diagnostics launches cardiometabolic center at Cleveland HeartLab
Quest Diagnostics has doubled the footprint and employee count at Cleveland HeartLab since acquiring the Cleveland lab test innovator in 2017.
American City Business Journals · 09/26 10:00
More
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, accountable care organizations (ACOs) and direct contract entities (DCEs). It is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provides insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company’s services primarily are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne and Quanum.

Webull offers kinds of Quest Diagnostics Inc stock information, including NYSE:DGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DGX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DGX stock methods without spending real money on the virtual paper trading platform.